De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
CVS Health Beheer
Beheer criteriumcontroles 3/4
De CEO CVS Health's is Karen Lynch, benoemd in Feb2021, heeft een ambtstermijn van 3.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 21.62M, bestaande uit 6.9% salaris en 93.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.04% van de aandelen van het bedrijf, ter waarde $ 31.82M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.6 jaar en 6.7 jaar.
Belangrijke informatie
Karen Lynch
Algemeen directeur
US$21.6m
Totale compensatie
| Percentage CEO-salaris | 6.9% |
| Dienstverband CEO | 3.7yrs |
| Eigendom CEO | 0.04% |
| Management gemiddelde ambtstermijn | 2.6yrs |
| Gemiddelde ambtstermijn bestuur | 6.7yrs |
Recente managementupdates
Recent updates
CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08
CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$7b |
| Mar 31 2024 | n/a | n/a | US$7b |
| Dec 31 2023 | US$22m | US$2m | US$8b |
| Sep 30 2023 | n/a | n/a | US$9b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$21m | US$1m | US$4b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$8b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$20m | US$1m | US$8b |
| Sep 30 2021 | n/a | n/a | US$8b |
| Jun 30 2021 | n/a | n/a | US$7b |
| Mar 31 2021 | n/a | n/a | US$7b |
| Dec 31 2020 | US$11m | US$1m | US$7b |
Compensatie versus markt: De totale vergoeding ($USD 21.62M ) Karen } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 13.04M ).
Compensatie versus inkomsten: De vergoeding van Karen is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Karen Lynch (61 yo)
3.7yrs
Tenure
US$21,615,034
Compensatie
Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 3.7yrs | US$21.62m | 0.040% $ 31.1m | |
| Executive VP & CFO | less than a year | US$4.58m | 0.0028% $ 2.2m | |
| Executive VP of Ventures and Chief Digital | 2.3yrs | US$8.88m | 0.0032% $ 2.5m | |
| Executive VP | 1.7yrs | US$11.89m | 0.00078% $ 603.8k | |
| Executive VP | 2.9yrs | US$8.58m | 0.0037% $ 2.9m | |
| Senior Director of Business Development & CVS Health and Partner & Co-Founder | no data | geen gegevens | geen gegevens | |
| Senior VP | 5.9yrs | geen gegevens | 0.00067% $ 518.7k | |
| Executive VP & Chief Compliance Officer | no data | geen gegevens | geen gegevens | |
| Executive VP & Chief People Officer | less than a year | geen gegevens | geen gegevens | |
| Executive Vice President & President of CVS Caremark | 1.8yrs | geen gegevens | 0.0032% $ 2.5m | |
| Executive VP and Chief Customer & Experience Officer | 3.8yrs | geen gegevens | 0.0099% $ 7.7m | |
| VP & Chief Health Equity Officer | 3yrs | geen gegevens | geen gegevens |
2.6yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CVS wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 3.7yrs | US$21.62m | 0.040% $ 31.1m | |
| Independent Director | less than a year | US$195.42k | 0.00045% $ 348.4k | |
| Independent Chairman | 5.9yrs | US$576.50k | 0.00033% $ 255.5k | |
| Independent Director | 7.4yrs | US$301.50k | 0.00094% $ 727.7k | |
| Independent Director | 11.1yrs | US$321.50k | 0.0025% $ 2.0m | |
| Independent Director | 13.8yrs | US$321.50k | 0.0026% $ 2.0m | |
| Independent Director | 17.6yrs | US$321.50k | 0.0097% $ 7.5m | |
| Independent Director | 17.6yrs | US$321.50k | 0.0088% $ 6.8m | |
| Independent Director | 9.6yrs | US$301.50k | 0.00024% $ 185.8k | |
| Independent Director | 5.9yrs | US$318.17k | 0.0028% $ 2.2m | |
| Independent Director | 2.1yrs | US$301.50k | 0.00058% $ 449.0k | |
| Independent Director | less than a year | US$167.50k | 0.0011% $ 836.1k |
6.7yrs
Gemiddelde duur
67.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CVS wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.7 jaar).